Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

✍ Scribed by Kees Hendricksen; Antoine G. van der Heijden; Erik B. Cornel; Henk Vergunst; Theo M. de Reijke; Erika van Boven; Geert A. H. J. Smits; Rajiv Puri; Sigrid Gruijs; J. Alfred Witjes

• Publisher: Springer-Verlag
• Year: 2009
• Tongue: English
• Weight: 286 KB
• Volume: 27
• Category: Article
• ISSN: 0724-4983
• DOI: 10.1007/s00345-009-0382-4